Prolonged survival of an HIV-infected subject with severe lymphoproliferative disease and rhinocerebral mucormycosis.
Bongiovanni
Marco
M
Ranieri
Roberto
R
Ferrari
Daris
D
Codecà
Carla
C
Tartaro
Tiziana
T
Uziel
Lilj
L
D017088:AIDS-Related Opportunistic Infections / Q000000981:diagnostic imaging / Q000382:microbiology / Q000401:mortality; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging / Q000382:microbiology; D001927:Brain Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology / Q000401:mortality; D015658:HIV Infections / Q000150:complications / Q000401:mortality*; D006801:Humans; D008081:Liposomes / Q000627:therapeutic use; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000401:mortality; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology / Q000401:mortality; D011859:Radiography; D013101:Sphenoid Sinus / Q000382:microbiology; D015524:Sphenoid Sinusitis / Q000150:complications / Q000382:microbiology / Q000401:mortality; D016896:Treatment Outcome
D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B